|
|
|
|
|
4101.0: Tuesday, November 9, 2004: 12:30 PM-2:00 PM | |||
Poster | |||
| |||
| Learning Objectives: See individual abstracts. | |||
| Methadone stigma and the potential effect of sensitivity training for drug treatment staff Siara B. Andrews, PsyD, James L. Sorensen, PhD, Kevin Delucchi, PhD | |||
| Provision and patients’ use of opportunities for HIV testing in U.S. methadone and drug-free treatment programs in 2001 Shiela M. Strauss, PhD, Janetta Astone, PhD, Don C. Des Jarlais, PhD, Holly Hagan, PhD | |||
| Linkage to methadone upon release from incarceration: Project MOD Michelle McKenzie, MPH, Josiah D. Rich, MD, MPH, Stephanie L Sanford-Colby, MPH, David Shield, BA, Fang Ma, MPH, Marah Mattheus-Kairys, BA, Christina L. Anastacio, BSW, Grace E. Macalino, PhD | |||
| Making movies to prevent substance use among youth: The Methamphetamine Awareness Project (MAP) Katherine E. Laws, BA, Jeffrey R.W. Knudsen, MA, Matthew Margolis, BA | |||
| Advocacy development for substance use treatment: The example of methadone (MAT) treatment Jo L. Sotheran, PhD | |||
| Trends in drug-induced and opiate overdose death rates, hospitalizations and emergency department encounters in Connecticut, 1992-2002 Margaret M. Hynes, PhD, MPH, Lloyd M. Mueller, PhD | |||
| Confounding factors in the care of opioid-dependent peri-menopausal women: Implications for research and treatment Ellen L. Tuchman, PhD | |||
| Illicit drug use and HIV risk behaviors of young African-Americans Min Qi Wang, PhD, Joseph E Schumacher, Sacia Dear, Foster Cook | |||
| Hepatitis C virus infection among street-recruited injection drug users in San Juan, Puerto Rico Juan C. Reyes, EdD, Rafaela R. Robles, EdD, Héctor M. Colón, PhD, C. Amalia Marrero, MPH, Eddy Rios, PhD, MPH, Tomás D. Matos, MS, José M. Calderón, MS, Elizabeth W. Shepard, PA-C, MPH | |||
| Risks for sexual diffusion of HIV from IDUs to non-injectors William A. Zule, DrPH, Kara S. Riehman, PhD, Georgiy Bobashev, PhD, Wendee Wechsberg, PhD | |||
| See individual abstracts for presenting author's disclosure statement and author's information. | |||
| Organized by: | Alcohol, Tobacco, and Other Drugs | ||
| Endorsed by: | HIV/AIDS | ||